Effects of salicylic acid on post-ischaemic ventricular function and purine efflux in isolated mouse hearts

Biomarkers

Volumn 12, Issue 6, 2007, Pages 623-634

  Farthing, Don ^a,c   Gehr, Lynne ^b   Karnes, H Thomas ^a   Sica, Domenic ^c   Gehr, Todd ^c   Larus, Terri ^c   Farthing, Christine ^c   Xi, Lei ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute cardiac ischaemia; Contractile function; HPLC; Hypoxanthine; Inosine; Salicylic acid

Indexed keywords

BIOLOGICAL MARKER; BUFFER; HYPOXANTHINE; INOSINE; PURINE; PURINE NUCLEOSIDE PHOSPHORYLASE; SALICYLIC ACID;

ANIMAL TISSUE; ARTICLE; CELL RESPIRATION; CONTROLLED STUDY; EFFUSION; EX VIVO STUDY; HEART CONTRACTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FUNCTION; ISOLATED HEART; MALE; MOUSE; NONHUMAN; PREDICTION; PURINE SYNTHESIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; BIOMARKERS, PHARMACOLOGICAL; CELL RESPIRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INOSINE; MALE; MICE; MICE, INBRED ICR; MITOCHONDRIA, HEART; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; PERFUSION; PURINE-NUCLEOSIDE PHOSPHORYLASE; RECOVERY OF FUNCTION; REPRODUCIBILITY OF RESULTS; SALICYLIC ACID; TIME FACTORS; VENTRICULAR FUNCTION;

RATTUS;

EID: 35748973254     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500701605786     Document Type: Article

References (18)

1. Abarbanell, NR, Marcotte, MA, Schaible, BA and Aldinger, GE (2001) Prehospital management of rapid atrial fibrillation: Recommendations for treatment protocols. American Journal of Emergency Medicine, 19, pp. 6-9.
2. Antman, EM, Anbe, DT, Armstrong, PW, Bates, ER, Green, LA, Hand, M., Hochman, JS, Krumholz, HM, Kushner, FG, Lamas, GA, Mullany, CJ, Ornato, JP, Pearle, DL, Sloan, MA and Smith Jr, SC (2004) ACC/AHA Guidelines for management of patients with ST-elevation myocardial infarction. Journal of the American College of Cardiology, 44, pp. 671-719.
3. Carlin, G., Djursater, R., Smedegard, G. and Gerdin, B. (1985) Effect of anti-inflammatory drugs on xanthine oxidase and xanthine oxidase induced depolymerization of hyaluronic acid. Agents and Actions, 16, pp. 377-384.
4. Cronstein, BN, Van De Stouwe, M., Druska, L., Levin, RI and Weissmann, G. (1994) Nonsteroidal anti-inflammatory agents inhibit stimulated neutrophil adhesion to endothelium: Adensoine dependent and independent mechanisms. Inflammation, 18, pp. 323-334.
5. Evans, G., Packham, MA, Nishizawa, EE, Mustard, JF and Murphy, EA (1968) The effect of acetylsalicylic acid on platelet function. Journal of Experimental Medicine, 128, pp. 877-894.
6. Farthing, D., Gehr, L., Sica, D., Larus, T. and Karnes, HT (2006) High-performance liquid chromatography (HPLC) determination of inosine, a potential biomarker for initial cardiac ischemia, using isolated mouse hearts. Biomarkers, 11, pp. 449-459.
7. Farthing, D., Sica, D., Gehr, T., Wilson, B., Fakhry, I., Larus, T., Farthing, C. and Karnes, HT (2007) A simple and sensitive HPLC method for determination of inosine and hypoxanthine in human plasma from healthy volunteers and patients presenting with chest pain and potential acute cardiac ischemia. Journal of Chromatography B, 854, pp. 158-164.
8. Feldman, M. and Cryer, B. (1999) Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution. American Journal of Cardiology, 84, pp. 404-409.
9. Karmazyn, M. (1986) Contribution of prostaglandins to reperfusion-induced ventricular failure in isolated rat hearts. American Journal of Physiology (Heart and Circulatory Physiology), 251, pp. H133-H140.
10. Kosowsky, JM (2006) Thrombolysis for ST-elevation myocardial infarction in the emergency department. Critical Pathways in Cardiology, 5, pp. 141-146.
11. Masuoka, N. and Kubo, I. (2004) Characterization of xanthine oxidase inhibition by anacardic acids. Biochimica et Biophysica Acta, 1688, pp. 245-249.
12. Molderings, GJ and Schümann, HJ (1987) Influence of cyclooxygenase inhibitors and of lithium on the positive inotropic effect mediated by a1-adrenoceptors in guinea-pig left atrium. Naunyn-Schmiedeberg's Archives of Phamacology, 336, pp. 403-408.
13. Nulton-Persson, AC, Szweda, LI and Sadek, HA (2004) Inhibition of cardiac mitochondrial respiration by salicylic acid and acetylsalicylate. Journal of Cardiovascular Pharmacology, 44, pp. 591-595.
14. Rowland, M. and Riegelman, S. (1968) Pharmacokinetics of acetylsalicylic acid and salicylic acid after intravenous administration in man. Journal of Pharmaceutical Sciences, 57, pp. 1313-1319.
15. Schrör, K. (1997) Aspirin and platelets: The anti-platelet action of aspirin and its role in thrombosis treatment and prophylaxis. Seminars in Thrombosis and Hemostasis, 23, pp. 349-356.
16. Smith, MJH and Dawkins, PD (1971) Salicylate and enzymes. Journal of Pharmacy and Pharmacology, 23, pp. 729-744.
17. Vane, JR and Botting, RM (2003) The mechanism of action of aspirin. Thrombosis Research, 110, pp. 255-258.
18. Hess, ML and Kukreja, RC (1998) Ischemic preconditioning in isolated perfused mouse heart: Reduction in infarct size without improvement of post-ischemic ventricular function. Molecular and Cellular Biochemistry, 186, pp. 69-77.